The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Drug Addiction, Dysregulation of Reward, and Allostasis
Abstract
This paper reviews recent developments in the neurocircuitry and neurobiology of addiction from a perspective of allostasis. A model is proposed for brain changes that occur during the development of addiction that explain the persistent vulnerability to relapse long after drug-taking has ceased. Addiction is presented as a cycle of spiralling dysregulation of brain reward systems that progressively increases, resulting in the compulsive use and loss of control over drug-taking. The development of addiction recruits different sources of reinforcement, different neuroadaptive mechanisms, and different neurochemical changes to dysregulate the brain reward system. Counteradaptive processes such as opponent-process that are part of normal homeostatic limitation of reward function fail to return within the normal homeostatic range and are hypothesized to form an allostatic state. Allostasis from the addiction perspective is defined as the process of maintaining apparent reward function stability by changes in brain reward mechanisms. The allostatic state represents a chronic deviation of reward set point and is fueled not only by dysregulation of reward circuits per se, but also by the activation of brain and hormonal stress responses. The manifestation of this allostatic state as compulsive drug-taking and loss of control over drug-taking is hypothesized to be expressed through activation of brain circuits involved in compulsive behavior such as the cortico-striatal-thalamic loop…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Though valuation processes are fundamental to survival of the human species, hedonic dysregulation is at the root of an array of clinical disorders, including addiction, stress, and chronic pain, as evidenced by the allostatic shift in the relative salience of natural reward to drug reward observed among persons with severe substance use disorders.”
In the citing paper
“The emergence of negative affective symptoms, such as dysphoria, anxiety and irritability and, to a lesser extent, the somatic manifestations of withdrawal, serve as negative reinforcers that sustain the vicious cycle of addiction [23, 121, 132–134].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [132]
In the citing paper
“but reward insensitivity and negative reinforcement underlie the later and more severe stages(18–20).”
From A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder (2016) · cites this paper as [18]
In the citing paper
“Finally, allostatic theory asserts heightened brain reward sensitivity and positive reinforcement characterize the early stages of addiction(18), but reward insensitivity and negative reinforcement underlie the later and more severe stages(18–20).”
From A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder (2016) · cites this paper as [18]
In the citing paper
“Limitations included that the reexamination interval may not have been sufficient to observe the extent of neuroadaptative responses to alcohol(18)”
From A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder (2016) · cites this paper as [18]
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 3×
“Different types of allostatic load have been considered that may explain different types or gradients of morbidity (McEwen 1998a).”
BackgroundCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationDrugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Self-citation(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Cited by
Sorted by citations
Items 201–249 of 249
Gilpin, N. W., Stewart, R. B., Murphy, J. M., Li, T., & Badia‐Elder, N. E. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000065723.93234.1d · Cited by 76
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75
Self-citationGaznick, N., Tranel, D., McNutt, A., & Bechara, A. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt172 · Cited by 72
Negus, S. S., & Rice, K. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.127 · Cited by 70
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Craig, E. L., Zhao, B., Cui, J. Z., Novalen, M., Miksys, S., & Tyndale, R. F. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058719 · Cited by 59
Massaly, N., Morón, J. A., & Al-Hasani, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00480 · Cited by 59
Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals
Carcoba, L. M., Contreras, A. E., Cepeda-Benito, A., & Meagher, M. W. (2011) · Journal of Addictive Diseases · doi:10.1080/10550887.2011.581985 · Cited by 52
Jordi, E., Heiman, M., Marion-Poll, L., Guermonprez, P., Cheng, S. K., Nairn, A. C., Greengard, P., & Girault, J.-A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307116110 · Cited by 57
Multimodal neurocognitive markers of interoceptive tuning in smoked cocaine
de la Fuente, A., Sedeño, L., Vignaga, S. S., Ellmann, C., Sonzogni, S., Belluscio, L., García-Cordero, I., Castagnaro, E., Boano, M., Cetkovich, M., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0370-3 · Cited by 55
Abreu-Villaça, Y., Seidler, F. J., & Slotkin, T. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03368-7 · Cited by 55
Arnaldo, I., Corcoran, A. W., Friston, K. J., & Ramstead, M. J. D. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104590 · Cited by 56
Chester, J. A., Barrenha, G. D., Hughes, M. L., & Keuneke, K. J. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00763.x · Cited by 54
Post-traumatic stress disorder and opioid use disorder: a narrative review of conceptual models
Danovitch, I. (2016) · Journal of Addictive Diseases · doi:10.1080/10550887.2016.1168212 · Cited by 55
Mindfulness in Treatment Approaches for Addiction — Underlying Mechanisms and Future Directions
Rosenthal, A., Levin, M. E., Garland, E. L., & Romanczuk-Seiferth, N. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00372-w · Cited by 54
“Thus, in a kind of vicious circle, the attempt to preserve a dwindling sense of well-being through increased drug use can further dysregulate reward system function and exacerbate dysphoria, drug-related cuereactivity, and craving [49].”
BackgroundHuhn, A. S., Harris, J., Cleveland, H. H., Lydon, D. M., Stankoski, D., Cleveland, M. J., Deneke, E., & Bunce, S. C. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.012 · Cited by 53
Yacubian, J., & Büchel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.015 · Cited by 53
Repunte-Canonigo, V., Shin, W., Vendruscolo, L. F., Lefebvre, C., van der Stap, L., Kawamura, T., Schlosburg, J. E., Alvarez, M., Koob, G. F., Califano, A., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0593-5 · Cited by 52
Self-citationLow dispositional mindfulness predicts self-medication of negative emotion with prescription opioids
Garland, E. L., Hanley, A. W., Thomas, E. A., Knoll, P., & Ferraro, J. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000090 · Cited by 52
“64 C© 2014 American Society of Addiction Medicine addictive behavior may derive, in part, from the motivation to alleviate dysphoric affective states; this compulsive behavior may be driven by interconnections between the extended amygdala and striatum (Koob & LeMoal, 2001, 2008).”
BackgroundGarland, E. L., Howard, M. O., Zubieta, J.-K., & Froeliger, B. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000453400 · Cited by 50
From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa
Umberg, E. N., Shader, R. I., Hsu, L. K. G., & Greenblatt, D. J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318252464f · Cited by 52
Wolitzky-Taylor, K., Sewart, A., Vrshek-Schallhorn, S., Zinbarg, R., Mineka, S., Hammen, C., Bobova, L., Adam, E. K., & Craske, M. G. (2017) · Journal of Youth and Adolescence · doi:10.1007/s10964-016-0566-3 · Cited by 51
Controversies about the enhanced vulnerability of the adolescent brain to develop addiction
Bernheim, A., Halfon, O., & Boutrel, B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00118 · Cited by 49
Backes, E., & Hemby, S. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054965 · Cited by 48
Garland, E. L., Brown, S. M., & Howard, M. O. (2016) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9675-9 · Cited by 47
Cocaine addiction as a homeostatic reinforcement learning disorder.
Keramati, M., Durand, A., Girardeau, P., Gutkin, B., & Ahmed, S. H. (2017) · Psychological Review · doi:10.1037/rev0000046 · Cited by 44
Gorka, S. M., Lieberman, L., Phan, K. L., & Shankman, S. A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.034 · Cited by 47
Stress and opioid use disorder: A systematic review
MacLean, R. R., Armstrong, J. L., & Sofuoglu, M. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.05.034 · Cited by 43
The role of habits and motivation in human drug addiction: a reflection
Sjoerds, Z., Luigjes, J., van den Brink, W., Denys, D., & Yücel, M. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00008 · Cited by 40
Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect
Bevins, R. A., & Palmatier, M. I. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00009-3 · Cited by 42
Solecki, W., Ziolkowska, B., Krowka, T., Gieryk, A., Filip, M., & Przewlocki, R. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.002 · Cited by 39
Mindfulness, Mechanisms and Meaning: Perspectives From the Cognitive Neuroscience of Addiction
McConnell, P. A., & Froeliger, B. (2015) · Psychological Inquiry · doi:10.1080/1047840x.2015.1076701 · Cited by 37
Leeman, R. F., Rowland, B. H. P., Gebru, N. M., & Potenza, M. N. (2019) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2018.0129 · Cited by 35
Thomas, E. A., Mijangos, J. L., Hansen, P. A., White, S., Walker, D., Reimers, C., Beck, A. C., & Garland, E. L. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419855138 · Cited by 36
Mesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
Montagud-Romero, S., Reguilon, M. D., Roger-Sanchez, C., Pascual, M., Aguilar, M. A., Guerri, C., Miñarro, J., & Rodríguez-Arias, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.008 · Cited by 31
Wills, K. L., Vemuri, K., Kalmar, A., Lee, A., Limebeer, C. L., Makriyannis, A., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3575-5 · Cited by 29
Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators
Mukhara, D., Banks, M. L., & Neigh, G. N. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00309 · Cited by 26
Feingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.006 · Cited by 24
DeFulio, A., Brown, H. D., Davidson, R. M., Regnier, S. D., Kang, N., & Ehart, M. (2023) · Behavior Analysis in Practice · doi:10.1007/s40617-022-00730-8 · Cited by 22
Baker, A. K., & Garland, E. L. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000225 · Cited by 21
Biback, C., & Zack, M. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0064-9 · Cited by 20
Chronic opioid pretreatment potentiates the sensitization of fear learning by trauma
Pennington, Z. T., Trott, J. M., Rajbhandari, A. K., Li, K., Walwyn, W. M., Evans, C. J., & Fanselow, M. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0559-5 · Cited by 19
“Chronic opioid pretreatment potentiates SEFL independent of treatment frequency and bouts of acute withdrawal The experience of acute withdrawal is frequently posited to underlie the changes in negative affective states associated with addiction [20, 21].”
BackgroundShort- and Long-Lasting Consequences of In Vivo Nicotine Treatment on Hippocampal Excitability
Penton, R. E., Quick, M. W., & Lester, R. A. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4362-10.2011 · Cited by 19
Post-traumatic stress symptoms in pathological gambling: Potential evidence of anti-reward processes
Green, C. L., Nahhas, R. W., Scoglio, A. A., & Elman, I. (2017) · Journal of Behavioral Addictions · doi:10.1556/2006.6.2017.006 · Cited by 19
NIH symposium series: Ingestive mechanisms in obesity, substance abuse and mental disorders
Simansky, K. J. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.06.016 · Cited by 18
Song, N., Du, J., Gao, Y., & Yang, S. (2020) · Translational Neuroscience · doi:10.1515/tnsci-2020-0146 · Cited by 15
Kota, D., Alajaji, M., Bagdas, D., Selley, D. E., Sim-Selley, L. J., & Damaj, M. I. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.08.006 · Cited by 12
Czarnecki, D., Ziółkowski, M., Chodkiewicz, J., Długosz, A., Feldheim, J., Waszkiewicz, N., Kułak-Bejda, A., Gorzkiewicz, M., Budzyński, J., Junkiert-Czarnecka, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245892 · Cited by 9
Metadata
- Authors
- Koob, G.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, G
- Venue
- Neuropsychopharmacology
- Published
- 2001-02
- Volume
- 24
- Issue
- 2
- Pages
- 97-129
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W1989416066
- Cited by
- 2,953
- References
- 37
- Citations by year
- 2026: 72 · 2025: 94 · 2024: 73 · 2023: 105 · 2022: 85 · 2021: 136 · 2020: 162 · 2019: 124 · 2018: 118 · 2017: 139 · 2016: 130 · 2015: 148 · 2014: 141 · 2013: 140 · 2012: 140
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- National Institutes of Health (AA06420, AA08459, DK-26741)
- National Institute on Alcohol Abuse and Alcoholism (AA-06420, AA-08459)
- National Institute on Drug Abuse (DA04043, AA06420, R01DA004043)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drug addiction, allostasis, relapse vulnerability, opponent process theory, stress response, compulsive drug taking, neural adaptation, homeostasis
- MeSH terms
- Animals, Humans, Hypothalamo-Hypophyseal System, Models, Neurological, Nerve Net, Pituitary-Adrenal System, Reinforcement, Psychology, Reward, Stress, Physiological, Substance Withdrawal Syndrome, Temperance, Behavior, Addictive, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
